ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

Research Base Would Be Increased In Guideline Change

November 9, 1990

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978